beneath both equally Drake’s and Lynch’s versions, the expense of deleterious mutations is what drives mutation rates down (Drake 1991; Lynch 2010; Sung et al. 2012). consequently, underneath the two models, a rise in the typical cost of mutations would bring about a decrease in mutation fees. To